Previous 10 | Next 10 |
home / stock / mrk / mrk articles
On Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer has responded to concerns related to its COVID-...
Merck & Co Inc’s (NYSE:MRK) fourth-quarter 2023 sales reached $14.63 billion, up 6% Y/Y, beating the consensus of $14.50 billio...
With the Fed decision now in the rearview mirror, sentiment appears to have taken a turn for the better on the hopes of receiving strong earnings r...
HOOKIPA Pharma Inc (NASDAQ:HOOK) will focus its resources on prioritizing the clinical development of a randomized trial for its HB-200 progra...
Saturday, Merck & Co Inc (NYSE:MRK) announced results from the Phase 3 KEYNOTE-564 trial evaluating Keytruda for the adjuvant treatme...
The past week’s earnings were bordering on the negative, impacting trader sentiment, and the focus now shifts to the unfolding week that woul...
Merck & Co Inc (NYSE:MRK) announced results from the Phase 3 AMBASSADOR (A031501)/KEYNOTE-123 trial of Keytruda for the adjuvant treatment...
LAVA Therapeutics NV (NASDAQ:LVTX) has entered into a clinical trial collaboration and supply agreement with Merck & Co Inc (NYS...
A notable insider purchase on January 24, was reported by Caroline Litchfield, EVP & CFO at Merck & Co (NYSE:MRK), based on the most recent...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 04:59:00 ET Some might hesitate to invest in stocks during a bull run, like the one we are experiencing. They argue that equities are likely to be overvalued. However, it's possible to find reasonably valued picks in this environment, even among top high-quality stocks. And some ...
How one employee's upbringing and career journey have motivated her to fight inequities around the world NORTHAMPTON, MA / ACCESSWIRE / July 16, 2024 / For Priya Agrawal, health equity has been a lifelong concern and a guiding principle in the work she's done across industries. As a young...
Symposia will highlight work to overcome HIV-related stigma and discuss the evolving state of HIV treatment and prevention Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced upcoming data presentations and programming at the 25 th International ...